ËýÀÁ°Î©Á£±ê¤Ç¤¹¤Í¡¢¤È¤«¡¢¼ã¤¤´µ¼Ô¤µ¤ó¤Ë¸À¤¦¡£
¤Ç¤â¤³¤³¤Ç¡¢¤³¤¦Â³¤±¤ë¡£
¡ÖËýÀ¡×¤Ã¤Æ¤¤¤¦¤Î¤Ï¤º¤Ã¤ÈÁ°¤«¤é¤¢¤ë¤Ã¤Æ¤¤¤¦°ÕÌ£¤¸¤ã¤Ê¤¯¤Ã¤Æ¡¢¼å¤¤±ê¾É¤¬¤¯¤¹¤Ö¤Ã¤Æ¤ë¤Ã¤Æ¤¤¤¦°ÕÌ£¤Ê¤ó¤Ç¤¹¤è¡£
¤ª¤·¤Ã¤³¤Ë¤ÏÌÀ¤é¤«¤Ê±ê¾ÉºÙ˦¤Ï½Ð¤Æ¤¤¤Ê¤¤¤ó¤Ç¤¹¤±¤É¡¢Á°Î©Á£¤Î±ü¤Ë±ê¾É¤¬¤¯¤¹¤Ö¤Ã¤Æ¤¤¤ë¤ó¤Ç¤¹¡¢¤È¡£
¤¦¡¼¤ó¡¢Åö¤¿¤é¤º¤·¤â±ó¤«¤é¤º¤È¤¤¤Ã¤¿¶ì¤·¤¤É½¸½¤À¤¬¡¢¤½¤Î¤è¤¦¤ËÀâÌÀ¤·¤Æ¡¢´µ¼Ô¤µ¤ó¤Ë¤ÏǼÆÀ¤·¤Æ¤â¤é¤Ã¤Æ¤¤¤ë¡£
¡ÖËýÀ¡×¤È¤¤¤¦¤³¤È¤Ð¤Ï¡Ö¼£¤é¤Ê¤¤¡×¤È¤¤¤¦Éé¤Î¥¤¥á¡¼¥¸¤ËÏ¢¤Ê¤Ã¤Æ¤æ¤¯¡£
²ñ±¢Éô¤ÎÆÀ¤â¸À¤ï¤ì¤ÌÉÔ²÷´¶¤ò´¶¤¸¤Æ¤¤¤ë´µ¼Ô¤µ¤ó¤Ï¤È¤â¤¹¤ì¤Ð¥Ê¡¼¥Ð¥¹¤Ë¤Ê¤Ã¤Æ¤¤¤ë¡£
¤½¤³¤Ë¿À·Ð¤¬½¸Ã椷¤Æ¤ë¤Î¤«¤È»×¤ï¤ì¤ë¤è¤¦¤Ê´µ¼Ô¤µ¤ó¤Ë¤âÁø¶ø¤¹¤ë¤·¡¦¡¦¡£
¤½¤ó¤Ê¥Ò¥È¤Ë;·×¤Ë¡Ö¼£¤é¤Ê¤¤¤Î¤Ç¤Ï¤Ê¤¤¤«¡×¤È¤¤¤¦·üÇ°¤òÍ¿¤¨¤¿¤¯¤Ê¤¤¤Î¤À¡£
¤Ç¤â¤½¤Î°ìÊý¤Ç¡¢¤³¤Îɵ¤¤Ï¡¢¥Ò¥È¤è¤êÁ¡ºÙ¤Ê¿Í¤¬¤Ê¤ë¤Î¤Ç¡¢¤¦¤Þ¤¯¤½¤ì¤ÈÉÕ¤¹ç¤Ã¤Æ¤¯É¬Íפ¬¤¢¤ë¤Î¤Ç¤¹¤è¡¢¤È¤â¡¢¸À¤Ã¤Æ¤¤¤ë¤ó¤À¤±¤É¡£
Æñ¤·¤¤¡£
ºÇ¶á¤Ç¤Ï¡¢ËýÀÁ°Î©Á£±ê¤È¿ÇÃǤ·¤¿¿Í¤Ë¡¢É¬¤º¦Á¥Ö¥í¥Ã¥«¡¼¤âºÇ½é¤«¤é²Ã¤¨¤ë¤³¤È¤Ë¤·¤Æ¤¤¤ë¡£
ºÇ½é¤Ã¤«¤é¥Õ¥ë¥¹¥í¥Ã¥È¥ë¤Ç¹Ô¤¯¤ï¤±¤À¡£
¥¨¥Ó¥Ç¥ó¥¹¤¬¤¢¤ë¤ï¤±¤Ç¤Ï¤Ê¤¤¤¬¡¢¤½¤Î¤Û¤¦¤¬¸ú²Ì¤¬¤¢¤ë¤è¤¦¤Êµ¤¤¬¤·¤Æ¤¤¤ë¡£
¤½¤ì¤Ë¤·¤Æ¤â¡¢¤¤¤Þ¤À¤Ë¡¢ËýÀÁ°Î©Á£±ê¤ÎÉÂÂÖ¤ÏÆæ¤À¤é¤±¤À¡£
¾É¾õ¡¢Ç¢ÄÀÞÖ¡¢¥¹¥³¥¢¡¢Á°Î©Á£¥Þ¥Ã¥µ¡¼¥¸¡Ê¤á¤Ã¤¿¤Ë¤·¤Ê¤¤¤±¤É¡Ë¡¢¤Ç¡¢¿ÇÃǤĤ±¤Æ¡¢
¦Á¥Ö¥í¥Ã¥«¡¼¡¢¥Ë¥å¡¼¥¥Î¥í¥ó¡¢¿¢ÊªÀ½ºÞ¡¢´ÁÊýÌô¡¦¡¦»þ¤Ë¹à¥³¥ê¥ó¤È¤«¤âÍѤ¤¤Æ¼£ÎŤ¹¤ë¤±¤É¡¢·ë¹½¼êõ¤ê¤ÊÉôʬ¤â¤¢¤Ã¤¿¤ê¤¹¤ë¡£
Î×¾²¤Î¾ì¤Ç¤Ï¡¢¾É¾õ¤ò´ËϤ¹¤ë¤³¤È¤¬°ìÈÖ½ÅÍפÀ¡£
¤½¤Î¤¿¤á¤Ë¸ý¡Ê¥à¥ó¥Æ¥é¤È¤¤¤¦¤Î¤À¤±¤É¡Ë¤â»È¤¨¤Ð¡¢Ìô¤â»È¤¦¡£
¤º¤Ã¤ÈÁ°¤Ë¡¢MR¤ÎÊý¤¬¤¯¤À¤µ¤Ã¤¿ºý»Ò¤Ë¡¢
Brain functional and anatomical change in chronic prostatitis/chronic pelvic pain syndrome
Farmer M.A.,et al(J Urol 2011,186:117-124)¤È¤¤¤¦¤Î¤¬¤¢¤Ã¤¿¡£
ËýÀÁ°Î©Á£±ê¤Î´µ¼Ô¤µ¤ó¤Î¡¢Ç¾¤Îµ¡Ç½¤È¹½Â¤¤ÎÆÃħ¤òMRI¤Ç¸¡º÷¤·¤¿¤â¤Î¤À¡£
¤³¤Î·ë²Ì¡¢¹üÈ×¹ÐÆâ¤ÎáÖÄË»þ¤Ë¤Ï¡¢±¦Á°Æ¬Èé¼ÁÆâ¤Ë³èÀ²½¤¬¸«¤é¤ì¡¢¾É¾õ¤ÈÁê´Ø¤·¤¿¤È¤¤¤¦·ë²Ì¤À¤Ã¤¿¤½¤¦¤À¡£
¹Í»¡¤Ë¤Ï¤³¤ó¤Ê¤Õ¤¦¤Ë½ñ¤«¤ì¤Æ¤¤¤ë¡£
ËýÀŪ¤Ê¹üÈ×ÆâáÖÄˤ¬Ç¾¤ËÆðÛŪ¤Ê¿À·Ð¥¤¥ó¥×¥ê¥ó¥È¤ò»Ä¤·¡¢¤½¤ì¤¬²¿Ç¯¤â»Ä¸¤¹¤ë¤³¤È¤¬¼¨º¶¤µ¤ì¤ë¡¦¡¦¡£
²¿¤«Ç¼ÆÀ¹Ô¤¯¤è¤¦¤Ê¹Í»¡¤Ç¤¢¤ë¡£
¾ÉÎã¿ô¤Ï19Îã¤È¾¯¤Ê¤¤¤¬¡¢¤³¤¦¤¤¤Ã¤¿Ãæ¿õ¤ËÂФ¹¤ë¥¢¥×¥í¡¼¥Á¤Ï¡¢¤³¤Î¼À´µ¤Î¾É¾õ¤Î¿ºÌ¤µ¤ËÂФ¹¤ëÆÍÇ˸ý¤Ë¤Ê¤ë²ÄǽÀ¤¬¤¢¤ë¤«¤â¤·¤ì¤Ê¤¤¡£
ºòº£¡¢ËýÀáÖÄˤËÂФ¹¤ëÌôºÞ¤â²¿¼ïÎफ¥ê¥ê¡¼¥¹¤µ¤ì¡¢áÖÄˤ˴ؤ¹¤ë¸¦µæ¤â¤è¤ê°ìÁؿʤó¤Ç¤æ¤¯¤³¤È¤À¤í¤¦¡£
¡Ê¥Ú¥¤¥ó¡¦¥¯¥ê¥Ë¥Ã¥¯É¸ÜÖ¤·¤Æ¤ëÀèÀ¸¤âÁý¤¨¤Æ¤ë¤·¡¦¡¦¡Ë
²æ¡¹³«¶È°å¤â¡¢¤³¤ó¤¬¤é¤¬¤ê¤Ê¤¬¤é¤â¡¢¿·¤·¤¤Ãθ«¤Ë¼ª¤ò·¹¤±¤Ê¤¬¤é¡Ê·¹¤±¤ë¤È¸À¤¦¤è¤ê¤Ï¥¢¥ó¥Æ¥ÊÄ¥¤ê½ä¤é¤»¤ó¤È¾ðÊó¤Ê¤ó¤ÆÆþ¤Ã¤Æ¤³¤ó¤±¤É¡¦¡¦¡Ë¡¢¤è¤ê¤¤¤Ã¤½¤¦Îå¤ó¤Ç¤Þ¤¹¤ó¤Ç¡¢
¤Þ¤¢¤è¤í¤·¤¯¤ª´ê¤¤¤·¤Þ¤¹¤È¤¤¤¦¤³¤È¤Ç¡£
¤½¤¦¤Ê¤ó¤Ç¤¹¤è¤Í¡¢¤â¤¦»Ä½ë¤ª¸«Éñ¤¤¿½¤·¾å¤²¤Þ¤¹¡¢¤À¤Ã¤¿¤ó¤À¡£
*ËýÀÁ°Î©Á£±ê/¹üÈ×ÆâáÖÄ˾ɸõ·²¤Ï¡¢ÈçÇ¢´ïÀ¸¿£·Ï¤Î»ý³ŪÉÔ²÷´¶¤òÆÃħ¤È¤¹¤ë¸¶°øÉÔÌÀ¤Î¼À´µ¤Ç¡¢ÃËÀ¤Î5-10¡ó¤Çȯ¾É¤¹¤ë¡£
´Ø·¸¤Ê¤¤¤±¤ÉËÜÆü¤Îɱ¡¿©¡£